The Effect of Adding Pain Relievers to Local Anesthesia Before Preforming Drainage in Peritonsillar Abscess

Peritonsillar Abscess Clinical Trial

— pta  

Official title:

The Efficiency of DYPIRON and TRAMADOL in Addition to Local Anesthesia Prior to Incision and Drainage Procedure in Peritonsillar Abscess

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT01227200
• Other study ID #: emc100061ctil
• Status: Not yet recruiting
• Phase: N/A
• First received: October 21, 2010
• Last updated: October 22, 2010
• Start date: November 2011
• Est. completion date: December 2011

Study information

• Verified date: October 2010
• Source: HaEmek Medical Center, Israel
• Contact: shani fisher, RN BA
• Phone: 046494311
• Email: SUNSHAN2[@]GMAIL.COM
• Is FDA regulated: No
• Health authority: Israel: Clalit Health Services
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to find if adding oral pain relievers as DYPIRON and TRAMADOL in addition to the local anesthesia injection, can help reducing the pain intensity in patients who diagnosed as Suffering from peritonsillar abscess (PTA)and treated by incision and drainage .

Description:

Control group: the patient will get local anesthesia injection with Lidocain. After 5 minutes- the DR will preform the incision and drainage of the abscess.

Then the patient will be asked by the vas score, the the pain intensity that he feels.

Intervention group:the patient will get dypiron 4 ml and tramadol 50 mg. after 40 minutes,the patient will get local anesthesia injection with Lidocain. After 5 minutes- the DR will preform the incision and drainage of the abscess.then the patient will be asked by the vas score, the the pain intensity that he feels.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 32
• Est. completion date: December 2011
• Est. primary completion date: November 2011
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:patients with PTA in ages 18-65, who agreed to join the research -

Exclusion Criteria:cave to dypiron and/or tramadol, pregnant women, mental illness,soldiers.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Abscess
• Peritonsillar Abscess

Intervention

Drug:
• dypiron, tramadol
dypiron 4 ML, tramadol 50 mg flashtab

Locations

Country	Name	City	State
Israel	otolaryngology department, HaEmek mc	Afula
Israel	Otolaryngology department, HaEmek MC	Afula

Sponsors (1)

Lead Sponsor	Collaborator
HaEmek Medical Center, Israel

Country where clinical trial is conducted

Israel, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	the vas scale		40 min after giving the oral drugs	Yes